![Lymphoma Coalition logo](/sites/default/files/styles/square_card_l/public/media/images/media-2744.png.webp?itok=DzMExpOB)
Global Patient Survey on lymphoma and CLL
The UK report provides an insight into the impact of treatment and care for people living with lymphoma.
Read the UK report
Read the latest news and views from Lymphoma Action.
Use the drop down filter to find the most relevant news for you.
The UK report provides an insight into the impact of treatment and care for people living with lymphoma.
Read the UK report
New report finds two thirds of blood cancer patients are concerned about accessing the most effective treatment.
Charities urge Governments to minimise the impact of COVID-19 for people living with cancer.
New European guidelines give evidence-based recommendations for the diagnosis, treatment and follow-up of people with CLL.
Join #TeamLymphoma in November for an exciting virtual balloon race across Kenya’s Great Rift Valley!
This year will see a more comprehensive flu vaccination programme. Why is this and is it connected to COVID-19?
Never before has looking after our mental wellbeing been more important. This video from one of our live webinars focuses on coping strategies for looking after your mental health and wellbeing.
Lenalidomide plus rituximab is now available on the NHS in Scotland for relapsed or refractory follicular lymphoma, while ibrutinib has been approved for NHS use in people with relapsed or refractory Waldenström’s macroglobulinaemia.
If you have a health concern please don’t put it off - contact your GP.
Lymphoma Action ensure that the patient voice is heard at HTAs, resulting in better access to the latest treatments.